Hologic Stock Analysis

HOLX Stock  USD 79.73  0.76  0.96%   
Hologic is undervalued with Real Value of 83.4 and Target Price of 86.62. The main objective of Hologic stock analysis is to determine its intrinsic value, which is an estimate of what Hologic is worth, separate from its market price. There are two main types of Hologic's stock analysis: fundamental analysis and technical analysis.
The Hologic stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Hologic is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. Hologic Stock trading window is adjusted to America/New York timezone.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

Hologic Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The book value of Hologic was currently reported as 21.34. The company has Price/Earnings To Growth (PEG) ratio of 1.27. Hologic had not issued any dividends in recent years. The entity had 2:1 split on the 3rd of April 2008. Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for womens health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts. Hologic operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 6705 people. To learn more about Hologic call Stephen MacMillan at 508 263 2900 or check out https://www.hologic.com.

Hologic Quarterly Total Revenue

987.9 Million

Hologic Investment Alerts

Hologic generated a negative expected return over the last 90 days
Hologic has a strong financial position based on the latest SEC filings
Over 99.0% of the company shares are owned by institutional investors
Latest headline from investing.com: Earnings call Hologic posts strong Q4 and FY 2024 results, eyes growth

Hologic Upcoming and Recent Events

Earnings reports are used by Hologic to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
1st of February 2024
Upcoming Quarterly Report
View
6th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of November 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View

Hologic Largest EPS Surprises

Earnings surprises can significantly impact Hologic's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2006-01-24
2005-12-310.070.06-0.0114 
2005-11-02
2005-09-300.090.10.0111 
2005-04-27
2005-03-310.060.070.0116 
View All Earnings Estimates

Hologic Environmental, Social, and Governance (ESG) Scores

Hologic's ESG score is a quantitative measure that evaluates Hologic's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Hologic's operations that may have significant financial implications and affect Hologic's stock price as well as guide investors towards more socially responsible investments.

Hologic Thematic Classifications

In addition to having Hologic stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Obamacare Repeal Idea
Obamacare Repeal
Large healthcare related equities associated with Obamacare
SRI Sustainable Growth Idea
SRI Sustainable Growth
Large and mid-sized companies that operate under the guidelines of socially responsible investing - SRI

Hologic Stock Institutional Investors

Shares
Ameriprise Financial Inc2024-06-30
3.5 M
Amvescap Plc.2024-06-30
3.4 M
Renaissance Technologies Corp2024-09-30
2.8 M
Black Creek Investment Management Inc2024-09-30
2.7 M
Manufacturers Life Insurance Co2024-09-30
2.6 M
Northern Trust Corp2024-09-30
2.5 M
Dimensional Fund Advisors, Inc.2024-09-30
2.5 M
Norges Bank2024-06-30
2.4 M
Bank Of America Corp2024-06-30
2.4 M
Vanguard Group Inc2024-09-30
27 M
Blackrock Inc2024-06-30
23.1 M
Note, although Hologic's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Hologic Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 18.34 B.

Hologic Profitablity

The company has Profit Margin (PM) of 0.18 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.24 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.24.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.16  0.17 
Return On Capital Employed 0.11  0.08 
Return On Assets 0.09  0.09 
Return On Equity 0.15  0.16 

Management Efficiency

Hologic has return on total asset (ROA) of 0.0645 % which means that it generated a profit of $0.0645 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1385 %, meaning that it created $0.1385 on every $100 dollars invested by stockholders. Hologic's management efficiency ratios could be used to measure how well Hologic manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Hologic's Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to rise to 0.09 in 2024, whereas Return On Capital Employed is likely to drop 0.08 in 2024. At this time, Hologic's Asset Turnover is fairly stable compared to the past year.
Last ReportedProjected for Next Year
Book Value Per Share 21.76  22.85 
Tangible Book Value Per Share 3.57  3.75 
Enterprise Value Over EBITDA 15.10  15.86 
Price Book Value Ratio 3.74  3.56 
Enterprise Value Multiple 15.10  15.86 
Price Fair Value 3.74  3.56 
Enterprise Value1.9 BB
The decision-making processes within Hologic are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Operating Margin
0.2436
Profit Margin
0.1759
Beta
0.986
Return On Assets
0.0645
Return On Equity
0.1385

Technical Drivers

As of the 26th of November, Hologic retains the insignificant Risk Adjusted Performance, standard deviation of 1.23, and Market Risk Adjusted Performance of (0.08). Hologic technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Hologic Price Movement Analysis

Execute Study
The output start index for this execution was eleven with a total number of output elements of fifty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Hologic middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Hologic. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Hologic Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Hologic insiders, such as employees or executives, is commonly permitted as long as it does not rely on Hologic's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Hologic insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Hologic Outstanding Bonds

Hologic issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Hologic uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Hologic bonds can be classified according to their maturity, which is the date when Hologic has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Hologic Predictive Daily Indicators

Hologic intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Hologic stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Hologic Corporate Filings

F4
18th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
F4
12th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
8th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
7th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
4th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F3
4th of October 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
8K
13th of September 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Hologic Forecast Models

Hologic's time-series forecasting models are one of many Hologic's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Hologic's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Hologic Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Hologic prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Hologic shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Hologic. By using and applying Hologic Stock analysis, traders can create a robust methodology for identifying Hologic entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.21  0.23 
Operating Profit Margin 0.22  0.23 
Net Profit Margin 0.20  0.21 
Gross Profit Margin 0.55  0.39 

Current Hologic Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Hologic analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Hologic analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
86.62Buy19Odds
Hologic current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Hologic analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Hologic stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Hologic, talking to its executives and customers, or listening to Hologic conference calls.
Hologic Analyst Advice Details

Hologic Stock Analysis Indicators

Hologic stock analysis indicators help investors evaluate how Hologic stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Hologic shares will generate the highest return on investment. By understating and applying Hologic stock analysis, traders can identify Hologic position entry and exit signals to maximize returns.
Begin Period Cash Flow2.8 B
Common Stock Shares Outstanding237.6 M
Total Stockholder Equity5.1 B
Quarterly Earnings Growth Y O Y1.116
Property Plant And Equipment Net537.8 M
Cash And Short Term Investments2.3 B
Cash2.2 B
Accounts Payable786.8 M
Net Debt374.4 M
50 Day M A80.4448
Total Current LiabilitiesB
Other Operating Expenses3.1 B
Non Current Assets Total5.3 B
Forward Price Earnings18.5185
Non Currrent Assets Other410.8 M
Stock Based Compensation82.3 M

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.